Ionis Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS
Last updated:
Abstract:
Dosage regimens for SOD1-targeting antisense oligonucleotides, and salts thereof, are provided. These dosage regimens find use in the treatment of subjects having or at risk of developing amyotrophic lateral sclerosis.
Status:
Application
Type:
Utility
Filling date:
12 Dec 2019
Issue date:
10 Mar 2022